Evidence map›Paper›PMID 39328468›Full record

ArticleJournal of pathology informatics2024

LVI-PathNet: Segmentation-classification pipeline for detection of lymphovascular invasion in whole slide images of lung adenocarcinoma.

Anna Timakova, Vladislav Ananev, Alexey Fayzullin, Egor Zemnuhov, Egor Rumyantsev, Andrey Zharov, Nicolay Zharkov, Varvara Zotova, Elena Shchelokova, Tatiana Demura and 2 more

Abstract read
In one paragraph

Article in Journal of pathology informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna TimakovaInstitute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow 119991, Russia.
Vladislav AnanevMedical Informatics Laboratory, Yaroslav-the-Wise Novgorod State University, 41 B. St. Petersburgskaya, Veliky Novgorod 173003, Russia.
Alexey FayzullinInstitute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow 119991, Russia.
Egor ZemnuhovMedical Informatics Laboratory, Yaroslav-the-Wise Novgorod State University, 41 B. St. Petersburgskaya, Veliky Novgorod 173003, Russia.
Egor RumyantsevMedical Informatics Laboratory, Yaroslav-the-Wise Novgorod State University, 41 B. St. Petersburgskaya, Veliky Novgorod 173003, Russia.
Andrey ZharovHelmholtz National Medical Research Center for Eye Diseases, 14/19 Sadovaya- Chernogryazskaya, Moscow 105062, Russia.
Nicolay ZharkovInstitute for Morphology and Digital Pathology, Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow 119991, Russia.
Varvara ZotovaMedical Informatics Laboratory, Yaroslav-the-Wise Novgorod State University, 41 B. St. Petersburgskaya, Veliky Novgorod 173003, Russia.
Elena ShchelokovaInstitute for Morphology and Digital Pathology, Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow 119991, Russia.
Tatiana DemuraInstitute for Morphology and Digital Pathology, Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow 119991, Russia.
Peter TimashevInstitute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya st., Moscow 119991, Russia.
Vladimir MakarovMedical Informatics Laboratory, Yaroslav-the-Wise Novgorod State University, 41 B. St. Petersburgskaya, Veliky Novgorod 173003, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphovascular invasion (LVI) in lung cancer is a significant prognostic factor that influences treatment and outcomes, yet its reliable detection is challenging due to interobserver variability. This study aims to develop a deep learning model for LVI detection using whole slide images (WSIs) and evaluate its effectiveness within a pathologist's information system. Experienced pathologists annotated blood vessels and invading tumor cells in 162 WSIs of non-mucinous lung adenocarcinoma sourced from two external and one internal datasets. Two models were trained to segment vessels and identify images with LVI features. DeepLabV3+ model achieved an Intersection-over-Union of 0.8840 and an area under the receiver operating characteristic curve (AUC-ROC) of 0.9869 in vessel segmentation. For LVI classification, the ensemble model achieved a F1-score of 0.9683 and an AUC-ROC of 0.9987. The model demonstrated robustness and was unaffected by variations in staining and image quality. The pilot study showed that pathologists' evaluation time for LVI detecting decreased by an average of 16.95%, and by 21.5% in "hard cases". The model facilitated consistent diagnostic assessments, suggesting potential for broader applications in detecting pathological changes in blood vessels and other lung pathologies.

Indexed as

Artificial intelligenceComputational pathologyDigital pathologyLung adenocarcinomaLymphovascular invasionWhole slide images

Identifiers

PMID39328468
PMCPMC11426154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.